Fukuyama-type congenital muscular dystrophy:: the first human disease to be caused by an ancient retrotransposal integration

被引:18
作者
Toda, T [1 ]
Kobayashi, K [1 ]
机构
[1] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Lab Genome Med,Minato Ku, Tokyo 1088639, Japan
来源
JOURNAL OF MOLECULAR MEDICINE-JMM | 1999年 / 77卷 / 12期
关键词
Fukuyama-type congenital muscular dystrophy fukutin; retrotransposon; founder mutation; neuronal migration disorder;
D O I
10.1007/s001099900065
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Fukuyama-type congenital muscular dystrophy (FCMD), one of the most common autosomal recessive disorders in the Japanese population, is characterized by congenital muscular dystrophy in combination with cortical dysgenesis (micropolygyria). Recently we identified on chromosome 9q31 the gene responsible for FCMD, which encodes a novel 461 amino acid protein that we have termed fukutin. Most FCMD-bearing chromosomes (87%) derive from a single ancestral founder, whose mutation consisted of a 3-kb retrotransposal insertion in the 3' noncoding region of the fukutin gene. Two independent point mutations causing premature termination confirmed that that this gene is responsible for FCMD. FCMD is the first human disease to be caused by an ancient retrotransposal integration. Fukutin contains an amino-terminal signal sequence, which together with results from transfection experiments suggests that it is an extracellular protein. Discovery of the FCMD gene represents an important step toward greater understanding of the pathogenesis of muscular dystrophies and also of normal brain development.
引用
收藏
页码:816 / 823
页数:8
相关论文
共 65 条
[1]   BETA-SARCOGLYCAN (A3B) MUTATIONS CAUSE AUTOSOMAL RECESSIVE MUSCULAR-DYSTROPHY WITH LOSS OF THE SARCOGLYCAN COMPLEX [J].
BONNEMANN, CG ;
MODI, R ;
NOGUCHI, S ;
MIZUNO, Y ;
YOSHIDA, M ;
GUSSONI, E ;
MCNALLY, EM ;
DUGGAN, DJ ;
ANGELINI, C ;
HOFFMAN, EP ;
OZAWA, E ;
KUNKEL, LM .
NATURE GENETICS, 1995, 11 (03) :266-273
[2]  
CHIJIIWA T, 1983, ANN OPHTHALMOL, V15, P921
[3]   Assignment of the muscle-eye-brain disease gene to 1p32-p34 by linkage analysis and homozygosity mapping [J].
Corman, B ;
Avela, K ;
Pihko, H ;
Santavuori, P ;
Talim, B ;
Topaloglu, H ;
de la Chapelle, A ;
Lehesjoki, AE .
AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 64 (01) :126-135
[4]   DIAGNOSTIC-CRITERIA FOR WALKER-WARBURG SYNDROME [J].
DOBYNS, WB ;
PAGON, RA ;
ARMSTRONG, D ;
CURRY, CJR ;
GREENBERG, F ;
GRIX, A ;
HOLMES, LB ;
LAXOVA, R ;
MICHELS, VV ;
ROBINOW, M ;
ZIMMERMAN, RL .
AMERICAN JOURNAL OF MEDICAL GENETICS, 1989, 32 (02) :195-210
[5]   CLASSIFICATION OF THE CEREBROOCULOMUSCULAR SYNDROME(S) - COMMENTARY [J].
DOBYNS, WB .
BRAIN & DEVELOPMENT, 1993, 15 (03) :242-244
[6]   Yayoi era mutation disrupts brain and muscle [J].
Eberhart, DE ;
Curran, T .
NATURE MEDICINE, 1998, 4 (09) :1002-1003
[7]   MEMBRANE ORGANIZATION OF THE DYSTROPHIN-GLYCOPROTEIN COMPLEX [J].
ERVASTI, JM ;
CAMPBELL, KP .
CELL, 1991, 66 (06) :1121-1131
[8]  
FOWLER M, 1973, CLIN STUDIES MYOLO 2, P192
[9]  
FUKUYAMA Y, 1981, BRAIN DEV-JPN, V3, P1
[10]   A GENETIC-STUDY OF THE FUKUYAMA TYPE CONGENITAL MUSCULAR-DYSTROPHY [J].
FUKUYAMA, Y ;
OHSAWA, M .
BRAIN & DEVELOPMENT, 1984, 6 (04) :373-390